IE43802B1 - Novel-n-aryl-n-(1-l-4-piperidinyl)-arylacetamides - Google Patents
Novel-n-aryl-n-(1-l-4-piperidinyl)-arylacetamidesInfo
- Publication number
- IE43802B1 IE43802B1 IE2095/76A IE209576A IE43802B1 IE 43802 B1 IE43802 B1 IE 43802B1 IE 2095/76 A IE2095/76 A IE 2095/76A IE 209576 A IE209576 A IE 209576A IE 43802 B1 IE43802 B1 IE 43802B1
- Authority
- IE
- Ireland
- Prior art keywords
- parts
- group
- piperidinyl
- formula
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61513175A | 1975-09-23 | 1975-09-23 | |
US71375676A | 1976-08-12 | 1976-08-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE43802L IE43802L (en) | 1977-03-23 |
IE43802B1 true IE43802B1 (en) | 1981-06-03 |
Family
ID=27087421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2095/76A IE43802B1 (en) | 1975-09-23 | 1976-09-22 | Novel-n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
Country Status (29)
Country | Link |
---|---|
JP (1) | JPS6016417B2 (en:Method) |
AT (1) | AT363935B (en:Method) |
AU (1) | AU510029B2 (en:Method) |
BG (1) | BG27543A3 (en:Method) |
CA (1) | CA1068271A (en:Method) |
CH (1) | CH628623A5 (en:Method) |
CS (1) | CS222663B2 (en:Method) |
DE (1) | DE2642856A1 (en:Method) |
DK (1) | DK150478C (en:Method) |
ES (1) | ES451768A1 (en:Method) |
FI (1) | FI61482C (en:Method) |
FR (1) | FR2325377A1 (en:Method) |
GB (1) | GB1539473A (en:Method) |
GR (1) | GR58469B (en:Method) |
HU (1) | HU172964B (en:Method) |
IE (1) | IE43802B1 (en:Method) |
IL (1) | IL50522A (en:Method) |
IT (1) | IT1073893B (en:Method) |
LU (1) | LU75837A1 (en:Method) |
NL (1) | NL187267C (en:Method) |
NO (1) | NO147672C (en:Method) |
NZ (1) | NZ181972A (en:Method) |
PH (1) | PH12497A (en:Method) |
PL (2) | PL117323B1 (en:Method) |
PT (1) | PT65631B (en:Method) |
RO (1) | RO70079A (en:Method) |
SE (1) | SE427839B (en:Method) |
SU (1) | SU747424A3 (en:Method) |
YU (1) | YU39973B (en:Method) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA765684B (en) * | 1975-09-23 | 1978-04-26 | Janssen Pharmaceutica Nv | Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
JPS62260786A (ja) * | 1986-05-08 | 1987-11-13 | 株式会社ヘキトク | 燻瓦の製造ラインにおける焼成工程後の表面仕上げ装置 |
JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor |
JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Dopamine 2 receptor antagonists are rapidly hydrolyzed |
SI2148873T1 (sl) | 2007-04-23 | 2013-01-31 | Janssen Pharmaceutica, N.V. | Derivati 4-alkoksipiridazina kot antagonisti receptorja dopamina 2 s hitro disociacijo |
JP2010525013A (ja) * | 2007-04-23 | 2010-07-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 高速解離性ドパミン2受容体アンタゴニストとしてのピリジン誘導体 |
KR101506156B1 (ko) | 2007-04-23 | 2015-03-26 | 얀센 파마슈티카 엔.브이. | 속해리성 도파민 2 수용체 길항제로서의 티아(디아)졸 |
CA2729313C (en) | 2008-07-03 | 2016-08-30 | Janssen Pharmaceutica Nv | Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists |
LT2307374T (lt) | 2008-07-31 | 2017-04-25 | Janssen Pharmaceutica Nv | Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai |
CN118496638B (zh) * | 2024-07-22 | 2024-11-22 | 海安浩驰科技有限公司 | 一种抗紫外车窗膜及其制备方法 |
-
1976
- 1976-09-06 NO NO763054A patent/NO147672C/no unknown
- 1976-09-08 NZ NZ181972A patent/NZ181972A/xx unknown
- 1976-09-16 FR FR7627870A patent/FR2325377A1/fr active Granted
- 1976-09-17 AU AU17878/76A patent/AU510029B2/en not_active Expired
- 1976-09-20 LU LU75837A patent/LU75837A1/xx unknown
- 1976-09-20 CA CA261,551A patent/CA1068271A/en not_active Expired
- 1976-09-20 RO RO7687590A patent/RO70079A/ro unknown
- 1976-09-21 JP JP51112527A patent/JPS6016417B2/ja not_active Expired
- 1976-09-21 GB GB39099/76A patent/GB1539473A/en not_active Expired
- 1976-09-21 IL IL50522A patent/IL50522A/xx unknown
- 1976-09-21 GR GR51742A patent/GR58469B/el unknown
- 1976-09-21 CH CH1194876A patent/CH628623A5/de not_active IP Right Cessation
- 1976-09-21 IT IT51370/76A patent/IT1073893B/it active
- 1976-09-22 FI FI762698A patent/FI61482C/fi not_active IP Right Cessation
- 1976-09-22 DK DK427876A patent/DK150478C/da active
- 1976-09-22 PT PT65631A patent/PT65631B/pt unknown
- 1976-09-22 PL PL1976216213A patent/PL117323B1/pl unknown
- 1976-09-22 PH PH18928A patent/PH12497A/en unknown
- 1976-09-22 NL NLAANVRAGE7610513,A patent/NL187267C/xx not_active IP Right Cessation
- 1976-09-22 PL PL19257876A patent/PL192578A1/xx not_active IP Right Cessation
- 1976-09-22 SE SE7610501A patent/SE427839B/xx not_active IP Right Cessation
- 1976-09-22 CS CS766139A patent/CS222663B2/cs unknown
- 1976-09-22 HU HU76JA00000767A patent/HU172964B/hu not_active IP Right Cessation
- 1976-09-22 YU YU2336/76A patent/YU39973B/xx unknown
- 1976-09-22 AT AT0702976A patent/AT363935B/de not_active IP Right Cessation
- 1976-09-22 ES ES451768A patent/ES451768A1/es not_active Expired
- 1976-09-22 IE IE2095/76A patent/IE43802B1/en unknown
- 1976-09-23 BG BG034265A patent/BG27543A3/xx unknown
- 1976-09-23 DE DE19762642856 patent/DE2642856A1/de active Granted
- 1976-09-23 SU SU762405548A patent/SU747424A3/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4126689A (en) | N-aryl-n-(1-alkyl-4-piperidinyl)-arylacetamides | |
IE42512B1 (en) | N-(4-piperidinyl)-n-phenylamides and-carbamates | |
US6610711B2 (en) | 4-phenylpiperidines for the treatment of pruritic dermatoses | |
US7074935B2 (en) | Methods for the syntheses of alfentanil, sufentanil and remifentanil | |
US4369184A (en) | 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives | |
US4179569A (en) | N-(4-piperidinyl)-N-phenylamides | |
NZ230956A (en) | Piperidinyl benzimidazole derivatives | |
HU196370B (en) | Process for producing piperidine derivatives and pharmaceutical compositions comprising such compounds | |
NZ195357A (en) | Quinoline derivatives and pharmaceutical compositions | |
IE43802B1 (en) | Novel-n-aryl-n-(1-l-4-piperidinyl)-arylacetamides | |
US3117139A (en) | 4-aryl-1-carbamylalkyl-piperidines | |
US4082755A (en) | 1-[(Diarylmethyl)aminoalkyl]piperidimes | |
US4197304A (en) | N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides | |
US4196210A (en) | N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides | |
IE922090A1 (en) | 2-(1-piperidyl)ethanol derivatives, their preparation and¹their therapeutic application | |
US4151286A (en) | N-aryl-N-(1-L-4-piperidinyl)-arylacetamides | |
ZA200007034B (en) | Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof. | |
US4197303A (en) | N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides | |
JP2002532471A (ja) | 5−ht1a受容体活性を有するアリールピペリジンおよびアリール−1,2,5,6−テトラヒドロピリジンアミド誘導体 | |
US4225606A (en) | N-Aryl-N-(1-L-4-piperidinyl)arylacetamides | |
CA1295332C (en) | Hydropyridine derivatives | |
US4208418A (en) | N-Aryl-N-(1-alkyl-4-piperidinyl)arylacetamides | |
US4198411A (en) | N-aryl-N-(1-L-4-piperidinyl)-arylaceytamides | |
WO2013084241A1 (en) | Compounds as inhibitors of renin | |
SE460418B (sv) | Derivat av 3-azabicyklo /3.3.1/ nonan-9-ol, foerfarande foer framstaellning av detta, farmaceutiska komposition och en mellanprodukt |